An investigation was conducted to study the beneficial effects of Ephedra alata monjauzeana crude extract (EamCE). The chemical profile was determined using RP-HPLC–ESI-QTOF-MS analysis, revealing the presence of twenty-one flavonoids and phenolic acids. A series of antioxidant assays was carried out using ten different methods. The EamCE has demonstrated a significant antioxidant potential, with interesting IC50 values not exceeding 40 µg/mL in almost activities. Likewise, a significant inhibition of key enzymes, involved in some health issues, such as Alzheimer’s disease, diabetes, hyperpigmentation, dermatological disorders, gastric/urinary bacterial infections, and obesity, was observed for the first time. The IC50 values ranged from 22.46 to 54.93. The anti-inflammatory and non-cytotoxic activities were assessed by heat-induced hemolysis and cell culture methods, respectively; the EamCE has shown a prominent effect in both tests, notably for the anti-inflammatory effect that was superior to the reference compound “diclofenac” (IC50: 71.03 ± 1.38 > 70.23 ± 0.99 (µg/mL)). According to these results, this plant could be used in a large spectrum as a food supplement, as a natural remedy for various physiological disorders and pathologies; and it might serve as a preventive and health care agent.
Community drinking water sources are increasingly contaminated by various point and non-point sources, with emerging organic contaminants and microbial strains posing health risks and disrupting ecosystems. This study explores the use of zinc oxide nanoparticles (ZnO-NPs) as a non-specific agent to address groundwater contamination and combat microbial resistance effectively. The ZnO-NPs were synthesized via a green chemistry approach, employing a sol-gel method with lemon peel aqueous extract. The catalyst was characterized using techniques including XRD, ATR-FTIR, SEM-EDAX, UV-DRS, BET, and Raman spectroscopy. ZnO-NPs were then tested for photodegradation of quinoline yellow dye (QY) under sunlight irradiation, as well as for their antibacterial and antioxidant properties. The ZnO-NP photocatalyst showed significant photoactivity, attributed to effective separation of photogenerated charge carriers. The efficiency of sunlight dye photodegradation was influenced by catalyst dosage (0.1–0.6 mg L−1), pH (3–11), and initial QY concentration (10–50 mg L−1). The study developed a first-order kinetic model for ZnO-NPs using the Langmuir–Hinshelwood equation, yielding kinetic constants of equilibrium adsorption and photodegradation of Kc = 6.632 × 10−2 L mg−1 and kH = 7.104 × 10−2 mg L−1 min−1, respectively. The results showed that ZnO-NPs were effective against Gram-positive bacterial strains and showed moderate antioxidant activity, suggesting their potential in wastewater disinfection to achieve sustainable development goals. A potential antibacterial mechanism of ZnO-NPs involving interactions with microbial cells is proposed. Additionally, Gaussian Process Regression (GPR) combined with an improved Lévy flight distribution (FDB-LFD) algorithm was used to model QY photodegradation by ZnO-NPs. The ARD-Exponential kernel function provided high accuracy, validated through residue analysis. Finally, an innovative MATLAB-based application was developed to integrate the GPR_FDB-LFD model and FDB-LFD algorithm, streamlining optimization for precise photodegradation rate predictions. The results obtained in this study show that the GPR and FDB-LFD approaches offer efficient and cost-effective methods for predicting dye photodegradation, saving both time and resources.
Background: Recently, the essential oil (EO) of Ammodaucus leucotrichus has attracted particular attention in hemi-synthesis due to the reactivity of its main monoterpenes.Objective: In vitro cytotoxic and antileishmanial activities of the EO and hemi-synthesized compounds were evaluated, and an in-silico simulation was conducted.Methods: The EO was characterized by GC-MS. Two benzodiazepines (C1, C2), benzimidazole (C3), and Schiff base (C4) were hemi-synthesized by an in situ condensation of its major monoterpenes (perillaldehyde) with different amine derivatives. Synthesized compounds and the EO were evaluated for their cytotoxic activity against laryngeal carcinoma-Hep2 and rhabdomyosarcoma-RD cell lines and for their antileishmanial activity against Leishmania (L) major. Molecular docking was performed to pin the binding interactions of active molecules.Results: A significant cytotoxic effect of benzodiazepines C1 and C2 was noted against Hep2 cells (IC50/C1 = 39.48 ±0.7 μM, IC50/C2 = 48.82±1.33 μM) and RD (IC50/C1 = 15.96±1.99 μM; IC50/C2 = 74.3±2.44 μM), while the EO highly inhibited Hep2 cell lines (IC50/EO = 17.3±0.85 μg/mL). C4 strongly inhibited L. major growth with an IC50 value of 8.00±1.37 Μμ. The docking scores of ligand-C4 on L. major pteridine reductase and L. major methionyl-tRNA synthetase and ligands-(C1, C2) on the human protein kinase and epidermal growth factor kinase presented significant affinity to the receptor active sites (ΔG from -7.7 to -8.8 kcal/mol).Conclusion: The cytotoxic effect of derivatives C1, C2, and EO, as well as the anti-parasitic effect of C4, may suggest them as effective bioactive agents or pharmaceutical probes.
Background: Schinus molle L. is a medicinal and aromatic plant widely used in folk medicine and commonly found in Algeria and the Mediterranean region. In the present work, we investigated the in vitro antioxidant, anti-cholinesterase, α-glucosidase inhibitory and photoprotective potentials of the Schinus molle L. plant’s extract/fractions. The metabolite profile of Schinus molle L. was analyzed using RP-HPLC and GC-MS. Methods: The antioxidant activity was assessed using different tests. The anticholinesterase activity was investigated by quantifying the acetylcholinesterase and butyrylcholinesterase inhibitory activities. The antidiabetic activity was investigated by α-glucosidase inhibition test, whereas photoprotective activity was evaluated by Sun Protection Factor (SPF) using spectrophotometry UV-Vis. The extracts were then subjected to RP-HPLC–PDA and GC–MS analysis. Results: Ethyl acetate and butanol fractions with high contents of total phenolics and flavonoids exhibited the strongest antioxidant activity. Ethyl acetate extract exhibited considerable enzyme inhibition potential on acetylcholinesterase, butyrylcholinesterase and α-glucosidase with percentages of inhibition of 99.08 ± 0.79%, 100% and 98.80 ± 0.18%, respectively. Furthermore, the ethyl acetate fraction showed high photoprotective activity with the Sun Protection Factor (SPF) value = 38,26 ± 0.73. Three phenolic acids (gallic, tannic and vanillic acids) and five flavonoids (myricetin, apigenin, naringenin, rutin and quercetin) were identified with RP-HPLC–PDA. Conclusion: These findings suggest that Schinus molle L. may be useful in the development of an alternative agent for oxidative stress, Alzheimer’s disease, diabetes and could be used as a natural sunscreen in pharmaceutics or cosmetic formulations.
23 December 2025 in Journal of the Australian Ceramic Society